Generation Bio Co (GBIO)

Apr 12, 2025

Needham & Company LLC Reaffirms Buy Rating for Generation Bio (NASDAQ:GBIO) - Defense World

Apr 12, 2025

Apr 08, 2025

GBIO stock plunges to 52-week low of $0.34 amid market challenges - Investing.com Australia

Apr 08, 2025

Apr 08, 2025

GBIO stock plunges to 52-week low of $0.34 amid market challenges By Investing.com - Investing.com South Africa

Apr 08, 2025

Apr 04, 2025

Layoff Tracker: Relay Will Cut 70 Employees, Affecting Research Budget by 75% - BioSpace

Apr 04, 2025

Apr 02, 2025

Generation Bio stock hits 52-week low at $0.4 amid steep decline - Investing.com Australia

Apr 02, 2025

Apr 02, 2025

Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference - The Manila Times

Apr 02, 2025

Apr 02, 2025

Generation Bio Takes Center Stage: CEO Fireside Chat at Major Healthcare Conference - Stock Titan

Apr 02, 2025

Apr 01, 2025

Generation Bio stock hits 52-week low at $0.4 amid steep decline By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

Charles Schwab Investment Management Inc. Cuts Stake in Generation Bio Co. (NASDAQ:GBIO) - Defense World

Apr 01, 2025

Mar 29, 2025

Generation Bio Co. (GBIO) Reports Q4 Loss, Tops Revenue Estimates - MSN

Mar 29, 2025

Mar 25, 2025

Generation Bio stock hits 52-week low at $0.47 By Investing.com - Investing.com South Africa

Mar 25, 2025

Mar 25, 2025

Generation Bio stock hits 52-week low at $0.47 - Investing.com India

Mar 25, 2025

Mar 18, 2025

Generation Bio’s (GBIO) Buy Rating Reaffirmed at Canaccord Genuity Group - Defense World

Mar 18, 2025

Mar 17, 2025

Generation Bio’s SWOT analysis: stock pivots to T-cell focus amid market caution By Investing.com - Investing.com South Africa

Mar 17, 2025

Mar 17, 2025

Generation Bio’s SWOT analysis: stock pivots to T-cell focus amid market caution - Investing.com Australia

Mar 17, 2025

Mar 17, 2025

Generation Bio’s (GBIO) Outperform Rating Reiterated at Wedbush - Defense World

Mar 17, 2025

Mar 16, 2025

Generation Bio Co. (NASDAQ:GBIO) Not Doing Enough For Some Investors As Its Shares Slump 29% - Simply Wall St

Mar 16, 2025

Mar 14, 2025

Generation Bio Co. Advances in Autoimmune Therapeutics - TipRanks

Mar 14, 2025

Mar 14, 2025

Generation Bio Co reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 14, 2025

Mar 14, 2025

Generation Bio stock holds Market Perform rating at JMP - Investing.com India

Mar 14, 2025

Mar 14, 2025

Generation Bio stock holds Market Perform rating at JMP By Investing.com - Investing.com UK

Mar 14, 2025

Mar 14, 2025

Generation Bio earnings missed by $0.02, revenue topped estimates - Investing.com South Africa

Mar 14, 2025

Mar 13, 2025

Generation Bio Co (GBIO) Q4 2024 Earnings: EPS Misses Estimate o - GuruFocus.com

Mar 13, 2025

Mar 13, 2025

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results - The Manila Times

Mar 13, 2025

Mar 13, 2025

Generation Bio Co. Advances T Cell-Selective siRNA Therapeutics for Autoimmune Diseases, Announces Robust Financial Position - Nasdaq

Mar 13, 2025

Mar 13, 2025

Generation Bio's Breakthrough: 98% T Cell Success Powers $185M Cash Runway Through 2027 - StockTitan

Mar 13, 2025

Mar 07, 2025

Generation Bio Co (GBIO)’s stock rises to 0.52 per share - US Post News

Mar 07, 2025

Mar 05, 2025

Generation Bio stock hits 52-week low at $0.52 By Investing.com - Investing.com Australia

Mar 05, 2025

Mar 04, 2025

A Guide To The Risks Of Investing In Generation Bio Co (GBIO) - Knox Daily

Mar 04, 2025

Mar 04, 2025

Generation Bio stock hits 52-week low at $0.52 - Investing.com

Mar 04, 2025

Mar 03, 2025

Generation Bio (GBIO) Expected to Announce Quarterly Earnings on Wednesday - Defense World

Mar 03, 2025

Mar 02, 2025

Contrasting Generation Bio (NASDAQ:GBIO) & Anthera Pharmaceuticals (OTCMKTS:ANTH) - Defense World

Mar 02, 2025

Mar 01, 2025

Generation Bio faces Nasdaq delisting over share price By Investing.com - Investing.com Canada

Mar 01, 2025

Feb 28, 2025

Generation Bio faces Nasdaq delisting over share price - Investing.com

Feb 28, 2025